Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
Year: 2016
Type: article
Institutions: Roche Pharma AG (Germany), F. Hoffmann-La Roche AG
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2509039973
